BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28369140)

  • 1. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    Yan T; Ke Y; Chen Y; Xu C; Yu C; Li Y
    PLoS One; 2017; 12(4):e0174735. PubMed ID: 28369140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.
    van Heerde MJ; Buijs J; Hansen BE; de Waart M; van Eijck CH; Kazemier G; Pek CJ; Poley JW; Bruno MJ; Kuipers EJ; van Buuren HR
    Dig Dis Sci; 2014 Jun; 59(6):1322-9. PubMed ID: 24385012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical strategies for differentiating autoimmune pancreatitis from pancreatic malignancy to avoid unnecessary surgical resection.
    Wu WC; Yao XZ; Jin DY; Wang DS; Lou WH; Qin XY
    J Dig Dis; 2013 Sep; 14(9):500-8. PubMed ID: 23692995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study on serum immunoglobulin and tumor marker levels in the patients with autoimmune pancreatitis and pancreatobiliary malignancies].
    Yoon H; Kim MH; Won SH; Park DH; Lee SS; Seo DW; Lee SK
    Korean J Gastroenterol; 2013 Jun; 61(6):327-32. PubMed ID: 23877213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
    Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Diagnosis of Autoimmune Pancreatitis From Pancreatic Cancer by Analysis of Serum Gelatinase Levels.
    Felix K; Dobiasch S; Gaida MM; Schneider K; Werner J; Martens E; Vandooren J; Opdenakker G
    Pancreas; 2016 Aug; 45(7):1048-55. PubMed ID: 26692441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis.
    Akamatsu M; Makino N; Ikeda Y; Matsuda A; Ito M; Kakizaki Y; Saito Y; Ishizawa T; Kobayashi T; Furukawa T; Ueno Y
    PLoS One; 2016; 11(7):e0158669. PubMed ID: 27380024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Amylase-α2A Autoantibodies in the Diagnosis of Autoimmune Pancreatitis.
    Sánchez Castañón M; Zuliani V; Amodio A; Campagnola P; Granato A; Gabbrielli A; Benini L; López Hoyos M; Frulloni L
    Pancreas; 2015 Oct; 44(7):1078-82. PubMed ID: 26335011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
    Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
    Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer.
    Detlefsen S; de Vos JD; Tanassi JT; Heegaard NHH; Fristrup C; Schaffalitzky de Muckadell OB
    Medicine (Baltimore); 2018 Aug; 97(31):e11641. PubMed ID: 30075546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
    Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology.
    Ferri MJ; Saez M; Figueras J; Fort E; Sabat M; López-Ben S; de Llorens R; Aleixandre RN; Peracaula R
    PLoS One; 2016; 11(1):e0147214. PubMed ID: 26808421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and imaging features of autoimmune pancreatitis with focal pancreatic swelling or mass formation: comparison with so-called tumor-forming pancreatitis and pancreatic carcinoma.
    Wakabayashi T; Kawaura Y; Satomura Y; Watanabe H; Motoo Y; Okai T; Sawabu N
    Am J Gastroenterol; 2003 Dec; 98(12):2679-87. PubMed ID: 14687817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis.
    Su SB; Qin SY; Chen W; Luo W; Jiang HX
    World J Gastroenterol; 2015 Apr; 21(14):4323-33. PubMed ID: 25892884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous occurrence of autoimmune pancreatitis and pancreatic cancer in patients resected for focal pancreatic mass.
    Macinga P; Pulkertova A; Bajer L; Maluskova J; Oliverius M; Smejkal M; Heczkova M; Spicak J; Hucl T
    World J Gastroenterol; 2017 Mar; 23(12):2185-2193. PubMed ID: 28405146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.